Monoclonal Antibodies: Targeted Therapy

Monoclonal Antibodies (MABs) are a type of targeted medicine remedy. These medicines honor and find specific proteins on cancer cells. There are numerous different MABs to treat cancer. They work in different ways to kill the cancer cell or stop it from growing. Monoclonal antibody remedy is a form of targeted treatment that uses lab-created antibodies that find and kill specific cancer cells. Physicians who treat cancer (oncologists) also use monoclonal antibody remedy to boost the vulnerable system’s capability to defend against cancer. Providers can use this treatment on its own or with other treatments.

    Related Conference of Monoclonal Antibodies: Targeted Therapy

    January 03-04, 2023

    International Congress on HIV-Aids and STD's

    London, UK
    February 15-16, 2023

    11th World Summit on Immunology and Immunotherapy

    Zurich, Switzerland
    February 20-21, 2023

    Global Summit on SARS-CoV-2 virus

    Madrid, Spain
    February 21-22, 2023

    4th European Congress on Hematology

    Zurich, Switzerland
    May 24-25, 2023

    37th International Conference on Immunology

    Vienna, Austria

    Monoclonal Antibodies: Targeted Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in